Evotec AG and the Roche group have announced a three-year collaboration to discover biomarkers that could be used to predict the dosage and efficacy of targeted oncology drugs under development at the Swiss multinational. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
